{
    "id": 30247,
    "fullName": "KLF4 A472D",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KLF4 A472D does not lie within any known function domains of the KLF4 protein (UniProt.org). A472D has been demonstrated to confer resistance to Egfr inhibitors in cell culture (PMID: 31924740), but has not been biochemically characterized and therefore, its effect on Klf4 protein function is unknown (PubMed, Mar 2020).",
            "references": [
                {
                    "id": 18062,
                    "pubMedId": 31924740,
                    "title": "KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31924740"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 9314,
        "geneSymbol": "KLF4",
        "terms": [
            "KLF4",
            "EZF",
            "GKLF"
        ]
    },
    "variant": "A472D",
    "createDate": "06/02/2019",
    "updateDate": "03/09/2020",
    "referenceTranscriptCoordinates": {
        "id": 179849,
        "transcript": "NM_001314052",
        "gDna": "chr9:g.107485878G>T",
        "cDna": "c.1415C>A",
        "protein": "p.A472D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17208,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, two metastatic colorectal cancer patients treated with Erbitux (cetuximab) developed resistance and were found to have acquired the mutation, KLF4 A472D, as detected in cell-free DNA (PMID: 31924740).",
            "molecularProfile": {
                "id": 32397,
                "profileName": "KLF4 A472D"
            },
            "therapy": {
                "id": 694,
                "therapyName": "Cetuximab",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 18062,
                    "pubMedId": 31924740,
                    "title": "KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31924740"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32397,
            "profileName": "KLF4 A472D",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 179848,
            "transcript": "NM_004235",
            "gDna": "chr9:g.107485776G>T",
            "cDna": "c.1415C>A",
            "protein": "p.A472D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 179849,
            "transcript": "NM_001314052",
            "gDna": "chr9:g.107485878G>T",
            "cDna": "c.1415C>A",
            "protein": "p.A472D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}